Faslodex, Aranesp Have Special Status Under Hospital Payment Rule
Executive Summary
CMS is proposing to allow separate Medicare payments for Faslodex, Trelstar and argatroban use in the hospital outpatient setting when the products become ineligible for "pass-through" payments in 2005